ATE431352T1 - Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen - Google Patents

Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen

Info

Publication number
ATE431352T1
ATE431352T1 AT01274809T AT01274809T ATE431352T1 AT E431352 T1 ATE431352 T1 AT E431352T1 AT 01274809 T AT01274809 T AT 01274809T AT 01274809 T AT01274809 T AT 01274809T AT E431352 T1 ATE431352 T1 AT E431352T1
Authority
AT
Austria
Prior art keywords
derivatives
carboplatin
present
pharmaceutical compositions
supermolecular
Prior art date
Application number
AT01274809T
Other languages
English (en)
Inventor
Jingzun Wang
Huisheng Qu
Lei Wang
Ting Wang
Original Assignee
Jingzun Wang
Huisheng Qu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jingzun Wang, Huisheng Qu filed Critical Jingzun Wang
Application granted granted Critical
Publication of ATE431352T1 publication Critical patent/ATE431352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01274809T 2001-11-30 2001-11-30 Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen ATE431352T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/001595 WO2003045962A1 (fr) 2001-11-30 2001-11-30 Derives de carboplatine supramoleculaires, leur preparation, compositions pharmaceutiques les contenant comme ingredient actif et utilisations de ces compositions

Publications (1)

Publication Number Publication Date
ATE431352T1 true ATE431352T1 (de) 2009-05-15

Family

ID=4574900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01274809T ATE431352T1 (de) 2001-11-30 2001-11-30 Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen

Country Status (8)

Country Link
US (1) US7259270B2 (de)
EP (1) EP1473298B1 (de)
JP (1) JP4235111B2 (de)
CN (1) CN100445293C (de)
AT (1) ATE431352T1 (de)
AU (1) AU2002221514A1 (de)
DE (1) DE60138739D1 (de)
WO (1) WO2003045962A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3280408B1 (de) * 2015-04-10 2019-10-23 Syn-Nat Products Enterprise LLC Verfahren zur herstellung von dicycloplatin
AU2016265922B2 (en) 2015-05-18 2021-05-20 Syn-Nat Products Enterprise LLC A pharmaceutical co-crystal and use thereof
BR112017027277A2 (pt) 2015-06-19 2018-09-04 Syn Nat Products Entpr Llc ?método para o tratamento ou prevenção de uma doença e métodos para matar uma célula?
BR112017027285A2 (pt) * 2015-06-19 2018-09-11 Syn Nat Products Entpr Llc ?cocristal, composição farmacêutica e método para o tratamento de uma doença?
US10428099B2 (en) 2015-06-25 2019-10-01 Syn-Nat Products Enterprise LLC Pharmaceutical co-crystal composition and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
CN1121380C (zh) * 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物

Also Published As

Publication number Publication date
CN100445293C (zh) 2008-12-24
WO2003045962A1 (fr) 2003-06-05
JP2005515195A (ja) 2005-05-26
US20050165093A1 (en) 2005-07-28
EP1473298A1 (de) 2004-11-03
DE60138739D1 (de) 2009-06-25
CN1558909A (zh) 2004-12-29
JP4235111B2 (ja) 2009-03-11
US7259270B2 (en) 2007-08-21
AU2002221514A1 (en) 2003-06-10
EP1473298B1 (de) 2009-05-13
EP1473298A4 (de) 2007-11-28

Similar Documents

Publication Publication Date Title
DE60108724D1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
YU69991A (sh) Derivati piridina
TR200000223T2 (tr) XA faktörünü engelleyen heterosiklik türevler
CY1108871T1 (el) Υποκατεστημενα παραγωγα αμινο-φουραν-2-υλ-οξεικου οξεος και αμινο-θειεν-2-οξεικου οξεος και η χρησιμοποιηση τους για τη θεραπεια ημικρανιας ή πονου
EE200000527A (et) Faktorit Xa pärssivad heterotsüklilised derivaadid
MX2022016263A (es) Derivados de ciclobutil-urea.
US5116949A (en) Benzoyl urea compound-albumin complex
ATE427944T1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
HU207333B (en) Process for producing polyoxymetallate compounds and pharmaceutical compositions containing them for treating patients infected with hiv-virus
ATE287874T1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
ES482788A1 (es) Un procedimiento para preparar derivados de flavano monodi- y tri-sustituidos.
BG93114A (bg) Производни на бензонафтиридин-1,8 ,методи за получаването им и състави които ги съдържат
ATE431352T1 (de) Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen
HUP0303379A2 (hu) Savérzékeny vegyületek, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ES2059471T3 (es) Un procedimiento para preparar un derivado de rodamina.
KR870006043A (ko) 피라진유도체 그 제조방법 및 약제조성물
Kovacic et al. Anticancer quinones and quinolines: mode of action via electron transfer and oxidative stress
EP0923932B1 (de) Zusammensetzung enthaltend ein antitumormittel
LV11542B (en) Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof
DE60119378D1 (de) Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten
BR0206311A (pt) Composto, composição farmacêutica, e, utilização de um composto
DE60124581D1 (de) Triazoloä4,5-düpyrimidinderivate als antithrombotische verbindungen
US1280127A (en) Arsenical compound.
Sakurai et al. Bacteriostatic activity of the nitrogen mustard N-oxides against Escherichia coli
JPS5920324A (ja) ポリシルセスキオキサン

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties